Neurocrine Biosciences (NBIX) R&D In Process (2019 - 2025)
Historic R&D In Process for Neurocrine Biosciences (NBIX) over the last 6 years, with Q4 2025 value amounting to $17.0 million.
- Neurocrine Biosciences' R&D In Process rose 46666.67% to $17.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $17.4 million, marking a year-over-year increase of 3920.0%. This contributed to the annual value of $17.4 million for FY2025, which is 3920.0% up from last year.
- As of Q4 2025, Neurocrine Biosciences' R&D In Process stood at $17.0 million, which was up 46666.67% from $300000.0 recorded in Q3 2025.
- In the past 5 years, Neurocrine Biosciences' R&D In Process ranged from a high of $143.9 million in Q1 2023 and a low of $100000.0 during Q1 2025
- Over the past 4 years, Neurocrine Biosciences' median R&D In Process value was $3.0 million (recorded in 2024), while the average stood at $19.9 million.
- Within the past 5 years, the most significant YoY rise in Neurocrine Biosciences' R&D In Process was 46666.67% (2025), while the steepest drop was 9833.33% (2025).
- Over the past 4 years, Neurocrine Biosciences' R&D In Process (Quarter) stood at $5.0 million in 2021, then surged by 2778.0% to $143.9 million in 2023, then crashed by 97.92% to $3.0 million in 2024, then surged by 466.67% to $17.0 million in 2025.
- Its last three reported values are $17.0 million in Q4 2025, $300000.0 for Q3 2025, and $100000.0 during Q1 2025.